Ra Medical Systems Stock Market Capitalization
Fundamental analysis of RA Medical allows traders to better anticipate movements in RA Medical's stock price by examining its financial health and performance throughout various phases of its business cycle.
RMED |
RA Medical Systems Company Market Capitalization Analysis
RA Medical's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current RA Medical Market Capitalization | 3.84 M |
Most of RA Medical's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RA Medical Systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
CompetitionBased on the recorded statements, the market capitalization of RA Medical Systems is about 3.84 M. This is 99.97% lower than that of the Health Care Equipment & Supplies sector and 99.97% lower than that of the Health Care industry. The market capitalization for all United States stocks is 99.98% higher than that of the company.
RMED Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses RA Medical's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of RA Medical could also be used in its relative valuation, which is a method of valuing RA Medical by comparing valuation metrics of similar companies.RA Medical is currently under evaluation in market capitalization category among its peers.
RMED Fundamentals
| Return On Equity | -3.25 | |||
| Return On Asset | -0.48 | |||
| Operating Margin | (307.60) % | |||
| Current Valuation | (8.89 M) | |||
| Shares Outstanding | 6.46 M | |||
| Shares Owned By Insiders | 36.84 % | |||
| Shares Owned By Institutions | 11.00 % | |||
| Number Of Shares Shorted | 81.45 K | |||
| Price To Book | 0.86 X | |||
| Price To Sales | 604.06 X | |||
| Revenue | 14 K | |||
| Gross Profit | (1.54 M) | |||
| EBITDA | (18.2 M) | |||
| Net Income | (26.86 M) | |||
| Cash And Equivalents | 13.66 M | |||
| Cash Per Share | 9.60 X | |||
| Total Debt | 124.17 K | |||
| Debt To Equity | 0.16 % | |||
| Current Ratio | 4.83 X | |||
| Book Value Per Share | 6.81 X | |||
| Cash Flow From Operations | (22.57 M) | |||
| Short Ratio | 0.13 X | |||
| Earnings Per Share | (35.78) X | |||
| Target Price | 7.0 | |||
| Number Of Employees | 14 | |||
| Beta | 0.18 | |||
| Market Capitalization | 3.84 M | |||
| Total Asset | 16.84 M | |||
| Retained Earnings | (205.14 M) | |||
| Working Capital | 9.26 M | |||
| Z Score | -1.42 | |||
| Net Asset | 16.84 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in RMED Stock
If you are still planning to invest in RA Medical Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RA Medical's history and understand the potential risks before investing.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |